id	sid	eid	entity	type
aji-165	102	1	nassar	PERSON
aji-165	102	2	asma	GPE
aji-165	102	3	amina alliouch -kerboua	PERSON
aji-165	102	4	hacene meriche	PERSON
aji-165	102	5	nassima sabiha gadiri	GPE
aji-165	102	6	frida	PERSON
aji-165	103	1	2025	CARDINAL
aji-165	104	1	calprotectin	PRODUCT
aji-165	104	2	crp	ORG
aji-165	105	1	asian	NORP
aji-165	105	2	8	CARDINAL
aji-165	105	3	1):104-19	DATE
aji-165	107	1	asian	NORP
aji-165	107	2	8	CARDINAL
aji-165	107	3	1	CARDINAL
aji-165	107	4	104	CARDINAL
aji-165	107	5	2025	DATE
aji-165	107	6	article no.aji.135189	ORG
aji-165	107	7	calprotectin	PRODUCT
aji-165	107	8	crp	ORG
aji-165	107	9	asma nassar	PERSON
aji-165	107	10	amina alliouch	PERSON
aji-165	107	11	hacene meriche	PERSON
aji-165	107	12	frida	PERSON
aji-165	107	13	saint therese	FAC
aji-165	107	14	uhc	GPE
aji-165	107	15	annaba	GPE
aji-165	107	16	algeria	GPE
aji-165	108	1	ibn sina uhc	PERSON
aji-165	108	2	annaba	GPE
aji-165	108	3	algeria	GPE
aji-165	112	1	05/05/2025	CARDINAL
aji-165	113	1	gastroentero	NORP
aji-165	113	2	annaba university hospital	ORG
aji-165	114	1	article https://doi.org/10.9734/aji/2025/v8i1165	LAW
aji-165	114	2	https://pr.sdiarticle5.com/review-history/135189 nassar et al.	PERSON
aji-165	115	1	asian	NORP
aji-165	115	2	j. immunol	PERSON
aji-165	115	3	8	CARDINAL
aji-165	115	4	1	CARDINAL
aji-165	116	1	104	CARDINAL
aji-165	116	2	2025	DATE
aji-165	116	3	105	CARDINAL
aji-165	116	4	2023 to september 2024	DATE
aji-165	116	5	77	CARDINAL
aji-165	116	6	calprotectin	PRODUCT
aji-165	116	7	fc	NORP
aji-165	118	1	fc	NORP
aji-165	119	1	77	CARDINAL
aji-165	119	2	53	CARDINAL
aji-165	119	3	68.9%	PERCENT
aji-165	119	4	24	CARDINAL
aji-165	119	5	31.1%	PERCENT
aji-165	121	1	21	CARDINAL
aji-165	121	2	39.62%	PERCENT
aji-165	121	3	25	CARDINAL
aji-165	121	4	32,47 %	PERCENT
aji-165	121	5	34	CARDINAL
aji-165	121	6	46.57%	PERCENT
aji-165	121	7	uc	ORG
aji-165	122	1	crp	ORG
aji-165	123	1	20	CARDINAL
aji-165	123	2	52.63%	PERCENT
aji-165	123	3	fc	NORP
aji-165	123	4	14	CARDINAL
aji-165	123	5	35.9%	PERCENT
aji-165	123	6	fc	NORP
aji-165	124	1	crp	ORG
aji-165	124	2	crp	ORG
aji-165	124	3	uc	ORG
aji-165	125	1	0.12	CARDINAL
aji-165	125	2	crp	ORG
aji-165	125	3	fc	ORG
aji-165	127	1	calprotectin	PRODUCT
aji-165	128	1	1	CARDINAL
aji-165	129	1	2024	CARDINAL
aji-165	129	2	2017	DATE
aji-165	130	1	2019	DATE
aji-165	131	1	fc	ORG
aji-165	132	1	uc	ORG
aji-165	133	1	today	DATE
aji-165	133	2	fc	ORG
aji-165	133	3	2021).although	CARDINAL
aji-165	133	4	fc	GPE
aji-165	133	5	crp	ORG
aji-165	133	6	crp	ORG
aji-165	134	1	fc	GPE
aji-165	135	1	2024	DATE
aji-165	137	1	crp	ORG
aji-165	138	1	2	CARDINAL
aji-165	138	2	annaba university hospital	ORG
aji-165	138	3	annaba	GPE
aji-165	138	4	algeria	GPE
aji-165	138	5	19 months	DATE
aji-165	138	6	february 9	DATE
aji-165	138	7	2023	CARDINAL
aji-165	138	8	september 30, 2024	DATE
aji-165	139	1	77	CARDINAL
aji-165	139	2	annaba university hospital	ORG
aji-165	140	1	29	CARDINAL
aji-165	140	2	48	CARDINAL
aji-165	140	3	age of 34 years	DATE
aji-165	140	4	34 years	DATE
aji-165	141	1	17 to 82 years	DATE
aji-165	141	2	0.6	CARDINAL
aji-165	142	1	nassar et al	PERSON
aji-165	143	1	asian	NORP
aji-165	143	2	j. immunol	PERSON
aji-165	143	3	8	CARDINAL
aji-165	143	4	1	CARDINAL
aji-165	144	1	104	CARDINAL
aji-165	144	2	2025	DATE
aji-165	144	3	106	CARDINAL
aji-165	144	4	fc	NORP
aji-165	144	5	crp	ORG
aji-165	148	1	77	CARDINAL
aji-165	148	2	2.1	CARDINAL
aji-165	148	3	inova	ORG
aji-165	148	4	fai	PERSON
aji-165	149	1	2.2	CARDINAL
aji-165	149	2	spss	ORG
aji-165	150	1	✓ chi-square	PERSON
aji-165	151	1	anova	ORG
aji-165	152	1	fc	NORP
aji-165	152	2	crp	ORG
aji-165	153	1	0.05	CARDINAL
aji-165	154	1	3	CARDINAL
aji-165	154	2	3.1	CARDINAL
aji-165	154	3	77	CARDINAL
aji-165	155	1	53	DATE
aji-165	155	2	68.9%	PERCENT
aji-165	155	3	24	DATE
aji-165	155	4	31.1%	PERCENT
aji-165	156	1	20	CARDINAL
aji-165	156	2	25.97%	PERCENT
aji-165	156	3	33	CARDINAL
aji-165	156	4	42.85%	PERCENT
aji-165	156	5	0.6	CARDINAL
aji-165	157	1	uc	ORG
aji-165	157	2	15	CARDINAL
aji-165	157	3	19.48%	PERCENT
aji-165	157	4	11	CARDINAL
aji-165	157	5	11.68%	PERCENT
aji-165	157	6	0.73	CARDINAL
aji-165	158	1	uc	ORG
aji-165	159	1	21	CARDINAL
aji-165	159	2	39.62%	PERCENT
aji-165	159	3	14	CARDINAL
aji-165	159	4	23.81%	PERCENT
aji-165	160	1	5	CARDINAL
aji-165	160	2	5.3%	PERCENT
aji-165	161	1	38	CARDINAL
aji-165	161	2	49.35%	PERCENT
aji-165	161	3	24	CARDINAL
aji-165	162	1	15	CARDINAL
aji-165	162	2	5 %	PERCENT
aji-165	162	3	anti-tnf	NORP
aji-165	162	4	12	CARDINAL
aji-165	162	5	15	CARDINAL
aji-165	162	6	6 %	PERCENT
aji-165	162	7	11	CARDINAL
aji-165	162	8	14.3%	PERCENT
aji-165	162	9	8 (10.4%	PERCENT
aji-165	162	10	6 (7.8%	PERCENT
aji-165	163	1	1	CARDINAL
aji-165	163	2	0.04	CARDINAL
aji-165	164	1	0.07	CARDINAL
aji-165	165	1	uc	ORG
aji-165	165	2	1	CARDINAL
aji-165	166	1	55	CARDINAL
aji-165	166	2	71.43%	PERCENT
aji-165	166	3	50	CARDINAL
aji-165	166	4	64.93%	PERCENT
aji-165	166	5	15	CARDINAL
aji-165	166	6	19.48 %	PERCENT
aji-165	166	7	14.28	CARDINAL
aji-165	166	8	7	CARDINAL
aji-165	166	9	9.09%	PERCENT
aji-165	166	10	3	CARDINAL
aji-165	166	11	3.9%	PERCENT
aji-165	167	1	0.0001	CARDINAL
aji-165	169	1	2	CARDINAL
aji-165	169	2	nassar et al	PERSON
aji-165	169	3	asian	NORP
aji-165	169	4	j. immunol	PERSON
aji-165	169	5	8	CARDINAL
aji-165	169	6	1	CARDINAL
aji-165	170	1	104	CARDINAL
aji-165	170	2	2025	DATE
aji-165	170	3	107	CARDINAL
aji-165	170	4	uc	ORG
aji-165	171	1	3	CARDINAL
aji-165	171	2	1	CARDINAL
aji-165	171	3	pearson chisquare	PERSON
aji-165	171	4	53 24	DATE
aji-165	171	5	68,9%	PERCENT
aji-165	171	6	uc	ORG
aji-165	171	7	20	CARDINAL
aji-165	171	8	33 9 15	TIME
aji-165	171	9	25,97%	PERCENT
aji-165	171	10	42,85%	PERCENT
aji-165	171	11	11,68%	PERCENT
aji-165	171	12	19,48%	PERCENT
aji-165	171	13	21 13	DATE
aji-165	171	14	14 39,62 %	PERCENT
aji-165	171	15	24,52 %	PERCENT
aji-165	171	16	26,41 %	PERCENT
aji-165	171	17	5 5,3%	PERCENT
aji-165	171	18	24 14	DATE
aji-165	171	19	31,17%	PERCENT
aji-165	171	20	18,18%	PERCENT
aji-165	171	21	5-asa	MONEY
aji-165	171	22	11	CARDINAL
aji-165	171	23	14,3 %	PERCENT
aji-165	171	24	10,4 %	PERCENT
aji-165	171	25	19,5 %	PERCENT
aji-165	171	26	7,8 %	PERCENT
aji-165	171	27	15,6 %	PERCENT
aji-165	172	1	1	CARDINAL
aji-165	172	2	2	CARDINAL
aji-165	173	1	40	CARDINAL
aji-165	173	2	51	DATE
aji-165	173	3	9%	PERCENT
aji-165	174	1	45%	PERCENT
aji-165	174	2	4(5	DATE
aji-165	174	3	19%	PERCENT
aji-165	175	1	6(7,79%	PERCENT
aji-165	175	2	5(6,49%	PERCENT
aji-165	175	3	1(1,3%	PERCENT
aji-165	176	1	15(19,5%	PERCENT
aji-165	176	2	15(19,5%	PERCENT
aji-165	176	3	11(14,28%	PERCENT
aji-165	176	4	1(1,3%	PERCENT
aji-165	177	1	2(2,6%	PERCENT
aji-165	178	1	2(2,6%	PERCENT
aji-165	178	2	55 50	CARDINAL
aji-165	178	3	3 %	PERCENT
aji-165	178	4	64,93	CARDINAL
aji-165	181	1	15	CARDINAL
aji-165	181	2	tableau uc	GPE
aji-165	181	3	p=0.04 nassar et al	PERSON
aji-165	181	4	asian	NORP
aji-165	181	5	j. immunol	PERSON
aji-165	181	6	8	CARDINAL
aji-165	181	7	1	CARDINAL
aji-165	182	1	104	CARDINAL
aji-165	182	2	2025	DATE
aji-165	182	3	108	CARDINAL
aji-165	182	4	3	CARDINAL
aji-165	183	1	3(3,9%	PERCENT
aji-165	184	1	2(2,6%	PERCENT
aji-165	185	1	2(2,6%	PERCENT
aji-165	186	1	4(5,2%	PERCENT
aji-165	186	2	0	CARDINAL
aji-165	187	1	20(25,97%	PERCENT
aji-165	188	1	7(9,09%	PERCENT
aji-165	188	2	6(7,8%	PERCENT
aji-165	189	1	3(3,9%	PERCENT
aji-165	189	2	12(15,6%	PERCENT
aji-165	189	3	3(3,9%	PERCENT
aji-165	189	4	23	CARDINAL
aji-165	189	5	9 8 3 16	TIME
aji-165	189	6	3 %	PERCENT
aji-165	189	7	3,9	CARDINAL
aji-165	189	8	3,9	CARDINAL
aji-165	189	9	0,25	CARDINAL
aji-165	190	1	crp	ORG
aji-165	190	2	3.2.1	CARDINAL
aji-165	190	3	fc	NORP
aji-165	190	4	77	CARDINAL
aji-165	190	5	34	DATE
aji-165	190	6	44.2%	PERCENT
aji-165	190	7	fc	NORP
aji-165	190	8	36	DATE
aji-165	190	9	46.8%	PERCENT
aji-165	190	10	fc	NORP
aji-165	190	11	7	DATE
aji-165	190	12	9.1%	PERCENT
aji-165	190	13	fc	NORP
aji-165	190	14	4	CARDINAL
aji-165	191	1	3.2.2	CARDINAL
aji-165	191	2	fc	NORP
aji-165	192	1	fc	ORG
aji-165	192	2	20	CARDINAL
aji-165	192	3	52.63%	PERCENT
aji-165	192	4	14	CARDINAL
aji-165	192	5	35.9%	PERCENT
aji-165	193	1	0.018	CARDINAL
aji-165	193	2	fc	NORP
aji-165	194	1	5	CARDINAL
aji-165	194	2	3.2.3	CARDINAL
aji-165	194	3	fc	GPE
aji-165	194	4	0.10	CARDINAL
aji-165	195	1	6	CARDINAL
aji-165	195	2	uc	ORG
aji-165	195	3	0.27	CARDINAL
aji-165	196	1	7	CARDINAL
aji-165	197	1	4	CARDINAL
aji-165	198	1	fc	NORP
aji-165	198	2	fc	NORP
aji-165	198	3	fc	NORP
aji-165	198	4	34	CARDINAL
aji-165	198	5	7 77 %	PERCENT
aji-165	200	1	100	CARDINAL
aji-165	200	2	5	CARDINAL
aji-165	200	3	fc	ORG
aji-165	200	4	fc	NORP
aji-165	200	5	fc	GPE
aji-165	200	6	fc	GPE
aji-165	200	7	20(52,63%	PERCENT
aji-165	201	1	18(47,37%	PERCENT
aji-165	201	2	0	CARDINAL
aji-165	202	1	14(35,9%	PERCENT
aji-165	202	2	18(46,15%	PERCENT
aji-165	202	3	7(17,9%	PERCENT
aji-165	202	4	34(44	CARDINAL
aji-165	202	5	2%	PERCENT
aji-165	203	1	8%	PERCENT
aji-165	203	2	7(9	DATE
aji-165	203	3	1%	PERCENT
aji-165	203	4	pearson chi-square	PERSON
aji-165	203	5	0,018	CARDINAL
aji-165	203	6	6	CARDINAL
aji-165	203	7	fc	ORG
aji-165	203	8	fc	NORP
aji-165	203	9	fc	GPE
aji-165	203	10	fc	NORP
aji-165	203	11	pearson chi-square	PERSON
aji-165	203	12	24	CARDINAL
aji-165	203	13	11(45,83%	PERCENT
aji-165	203	14	13(54,17%	PERCENT
aji-165	203	15	0	CARDINAL
aji-165	204	1	11(37,93%	PERCENT
aji-165	204	2	13(44,83%	PERCENT
aji-165	204	3	5(17,24%	PERCENT
aji-165	204	4	14	CARDINAL
aji-165	204	5	9(64,29%	PERCENT
aji-165	205	1	5(35,71%	PERCENT
aji-165	205	2	0	CARDINAL
aji-165	206	1	10	CARDINAL
aji-165	206	2	3(30%	PERCENT
aji-165	206	3	5(50%	PERCENT
aji-165	206	4	2(20%	PERCENT
aji-165	206	5	77	CARDINAL
aji-165	206	6	34(44,2%	PERCENT
aji-165	207	1	36(46,8%	PERCENT
aji-165	208	1	7(9,1%	PERCENT
aji-165	208	2	nassar et al	PERSON
aji-165	208	3	asian	NORP
aji-165	208	4	j. immunol	PERSON
aji-165	208	5	8	CARDINAL
aji-165	208	6	1	CARDINAL
aji-165	209	1	104	CARDINAL
aji-165	209	2	2025	DATE
aji-165	209	3	109	CARDINAL
aji-165	209	4	7	CARDINAL
aji-165	209	5	fc	NORP
aji-165	209	6	uc	ORG
aji-165	209	7	fc	NORP
aji-165	209	8	fc	GPE
aji-165	209	9	fc	NORP
aji-165	209	10	pearson chi-square	PERSON
aji-165	209	11	24	CARDINAL
aji-165	209	12	11(45,83%	PERCENT
aji-165	209	13	13(45,17%	PERCENT
aji-165	210	1	14	CARDINAL
aji-165	210	2	9(64,29%	PERCENT
aji-165	210	3	5(35,71%	PERCENT
aji-165	210	4	0	CARDINAL
aji-165	210	5	38) 20(52,63%	PERCENT
aji-165	210	6	18(47,37%	PERCENT
aji-165	211	1	crp	ORG
aji-165	211	2	34	CARDINAL
aji-165	211	3	46.57%	PERCENT
aji-165	211	4	6 mg	QUANTITY
aji-165	211	5	39	CARDINAL
aji-165	211	6	53.42%	PERCENT
aji-165	211	7	6 mg	QUANTITY
aji-165	211	8	crp	ORG
aji-165	211	9	uc	ORG
aji-165	212	1	fisher	ORG
aji-165	212	2	crp	ORG
aji-165	213	1	2	CARDINAL
aji-165	214	1	3.2.5	CARDINAL
aji-165	214	2	crp	ORG
aji-165	214	3	crp	ORG
aji-165	214	4	6 and ≥6	DATE
aji-165	214	5	fisher	ORG
aji-165	214	6	0.48	CARDINAL
aji-165	215	1	0.80	CARDINAL
aji-165	216	1	uc	ORG
aji-165	216	2	0.08	CARDINAL
aji-165	217	1	9	CARDINAL
aji-165	217	2	0.17	CARDINAL
aji-165	218	1	10	CARDINAL
aji-165	220	1	2	CARDINAL
aji-165	220	2	crp	ORG
aji-165	220	3	8	CARDINAL
aji-165	221	1	crp	ORG
aji-165	221	2	crp	ORG
aji-165	221	3	6 mg/l	QUANTITY
aji-165	221	4	37	CARDINAL
aji-165	221	5	18	CARDINAL
aji-165	221	6	48,65%	PERCENT
aji-165	221	7	19	DATE
aji-165	221	8	51,35%	PERCENT
aji-165	222	1	36	CARDINAL
aji-165	222	2	21	DATE
aji-165	222	3	58,33%	PERCENT
aji-165	222	4	15	CARDINAL
aji-165	222	5	41,67%	PERCENT
aji-165	222	6	73	CARDINAL
aji-165	222	7	39	DATE
aji-165	222	8	53,42%	PERCENT
aji-165	222	9	34	DATE
aji-165	222	10	46,57%	PERCENT
aji-165	222	11	9	CARDINAL
aji-165	222	12	crp	ORG
aji-165	222	13	24	CARDINAL
aji-165	222	14	14(58,33%	PERCENT
aji-165	222	15	10(41,67%	PERCENT
aji-165	223	1	29	CARDINAL
aji-165	223	2	16(55,17 %	PERCENT
aji-165	223	3	13(44,83%	PERCENT
aji-165	223	4	uc	ORG
aji-165	223	5	13	CARDINAL
aji-165	223	6	4(30,77%	PERCENT
aji-165	224	1	9(69,23%	PERCENT
aji-165	225	1	7	CARDINAL
aji-165	225	2	5(71,42%	PERCENT
aji-165	225	3	2(28,6%	PERCENT
aji-165	225	4	73	CARDINAL
aji-165	225	5	39	DATE
aji-165	225	6	53,42%	PERCENT
aji-165	225	7	34(46,57%	PERCENT
aji-165	225	8	10 20 30	DATE
aji-165	225	9	uc	ORG
aji-165	225	10	6 30	PERCENT
aji-165	225	11	6 6≥	CARDINAL
aji-165	225	12	nassar et al	PERSON
aji-165	225	13	asian	NORP
aji-165	225	14	j. immunol	PERSON
aji-165	225	15	8	CARDINAL
aji-165	225	16	1	CARDINAL
aji-165	226	1	104	CARDINAL
aji-165	226	2	2025	DATE
aji-165	226	3	110	CARDINAL
aji-165	226	4	10	CARDINAL
aji-165	227	1	crp	ORG
aji-165	227	2	uc	ORG
aji-165	227	3	crp	ORG
aji-165	227	4	24	CARDINAL
aji-165	227	5	14(58,33%	PERCENT
aji-165	227	6	10(41,67%	PERCENT
aji-165	228	1	0,17	DATE
aji-165	228	2	13	CARDINAL
aji-165	228	3	4(30,77%	PERCENT
aji-165	229	1	9(69,23%	PERCENT
aji-165	229	2	37	CARDINAL
aji-165	229	3	18(48,65%	PERCENT
aji-165	229	4	19(51,35%	PERCENT
aji-165	229	5	3.2.7	CARDINAL
aji-165	229	6	crp	ORG
aji-165	229	7	fc	NORP
aji-165	229	8	11	CARDINAL
aji-165	230	1	6 or <	QUANTITY
aji-165	231	1	0.06	CARDINAL
aji-165	231	2	12	CARDINAL
aji-165	232	1	3.3	CARDINAL
aji-165	232	2	fc	GPE
aji-165	232	3	crp 3.3.1	LAW
aji-165	232	4	fc	ORG
aji-165	232	5	uc	ORG
aji-165	232	6	fc	GPE
aji-165	233	1	13	CARDINAL
aji-165	233	2	3.3.2	CARDINAL
aji-165	233	3	531 mg/l	QUANTITY
aji-165	233	4	412.6 mg/l	QUANTITY
aji-165	234	1	751.71	CARDINAL
aji-165	234	2	879.82	CARDINAL
aji-165	236	1	two	CARDINAL
aji-165	236	2	73	DATE
aji-165	236	3	14	CARDINAL
aji-165	237	1	11	CARDINAL
aji-165	238	1	fc	ORG
aji-165	238	2	fc	GPE
aji-165	238	3	10(47,62%	PERCENT
aji-165	238	4	7(50%	PERCENT
aji-165	238	5	fc	GPE
aji-165	238	6	10(47,62%	PERCENT
aji-165	238	7	8(61,54%	PERCENT
aji-165	239	1	6(42,86%	PERCENT
aji-165	240	1	1(4,8%	PERCENT
aji-165	240	2	2(15,38%	PERCENT
aji-165	240	3	1 (7,14%	PERCENT
aji-165	241	1	12	CARDINAL
aji-165	242	1	crp	ORG
aji-165	242	2	5(38,46%	PERCENT
aji-165	243	1	9(64,29%	PERCENT
aji-165	243	2	crp	ORG
aji-165	244	1	6 mg	QUANTITY
aji-165	244	2	8(61,54%	PERCENT
aji-165	244	3	5(35,71%	PERCENT
aji-165	245	1	0,06	ORG
aji-165	245	2	13	CARDINAL
aji-165	246	1	fc	GPE
aji-165	246	2	14 531,11	DATE
aji-165	246	3	24	CARDINAL
aji-165	246	4	249,88 326,24	ORG
aji-165	246	5	14	CARDINAL
aji-165	247	1	14 531 751,71	CARDINAL
aji-165	247	2	10	CARDINAL
aji-165	247	3	879,82	DATE
aji-165	247	4	p=0,73 nassar et al	PERSON
aji-165	248	1	asian	NORP
aji-165	248	2	j. immunol	PERSON
aji-165	248	3	8	CARDINAL
aji-165	248	4	1	CARDINAL
aji-165	249	1	104	CARDINAL
aji-165	249	2	2025	DATE
aji-165	249	3	111	CARDINAL
aji-165	249	4	fc	NORP
aji-165	249	5	two	CARDINAL
aji-165	249	6	250 mg/l	QUANTITY
aji-165	249	7	258 mg/l	QUANTITY
aji-165	250	1	555.53	CARDINAL
aji-165	250	2	320	CARDINAL
aji-165	250	3	fc	NORP
aji-165	251	1	95	CARDINAL
aji-165	252	1	15	CARDINAL
aji-165	252	2	3.3.4	CARDINAL
aji-165	252	3	uc	ORG
aji-165	252	4	0.88	CARDINAL
aji-165	252	5	two	CARDINAL
aji-165	253	1	16	CARDINAL
aji-165	253	2	3.3.5	CARDINAL
aji-165	253	3	two	CARDINAL
aji-165	254	1	17	CARDINAL
aji-165	254	2	3.3.6	CARDINAL
aji-165	254	3	19.62 mg/l	QUANTITY
aji-165	254	4	12.06 mg/l	QUANTITY
aji-165	255	1	0.37	CARDINAL
aji-165	256	1	18	CARDINAL
aji-165	256	2	3.3.7	CARDINAL
aji-165	256	3	calprotectin	PERSON
aji-165	256	4	53	DATE
aji-165	257	1	19	CARDINAL
aji-165	257	2	15	CARDINAL
aji-165	258	1	24	CARDINAL
aji-165	258	2	320	PRODUCT
aji-165	258	3	29	CARDINAL
aji-165	258	4	555,53	CARDINAL
aji-165	258	5	16	CARDINAL
aji-165	259	1	uc	ORG
aji-165	259	2	14 18,12 15,76	QUANTITY
aji-165	259	3	24	CARDINAL
aji-165	259	4	17	CARDINAL
aji-165	260	1	13	CARDINAL
aji-165	260	2	15,54	CARDINAL
aji-165	260	3	7 6,84	CARDINAL
aji-165	260	4	5,76	CARDINAL
aji-165	260	5	18	CARDINAL
aji-165	262	1	24 19,62 38,12	TIME
aji-165	262	2	29 12.06 14,63	DATE
aji-165	262	3	asian	NORP
aji-165	262	4	j. immunol	PERSON
aji-165	262	5	8	CARDINAL
aji-165	262	6	1	CARDINAL
aji-165	263	1	104	CARDINAL
aji-165	263	2	2025	DATE
aji-165	263	3	112	CARDINAL
aji-165	263	4	19	CARDINAL
aji-165	263	5	fc	NORP
aji-165	263	6	127,40 403,21	DATE
aji-165	263	7	325,9 146,84	CARDINAL
aji-165	263	8	anova	ORG
aji-165	263	9	20	CARDINAL
aji-165	264	1	crp rate	PERSON
aji-165	264	2	7,99	CARDINAL
aji-165	265	1	20,67	CARDINAL
aji-165	265	2	11,1	CARDINAL
aji-165	265	3	13,15 23,82	CARDINAL
aji-165	265	4	anova	ORG
aji-165	265	5	3.3.8	CARDINAL
aji-165	265	6	38	DATE
aji-165	266	1	20	CARDINAL
aji-165	266	2	3.4	CARDINAL
aji-165	266	3	fc	ORG
aji-165	266	4	crp	ORG
aji-165	266	5	crp	ORG
aji-165	266	6	fc	GPE
aji-165	266	7	0.12	CARDINAL
aji-165	267	1	fc	NORP
aji-165	268	1	0.48	CARDINAL
aji-165	269	1	crp	ORG
aji-165	269	2	fc	ORG
aji-165	272	1	3	CARDINAL
aji-165	274	1	3	CARDINAL
aji-165	274	2	fc	GPE
aji-165	274	3	crp	ORG
aji-165	274	4	0,48 r=0,12	NORP
aji-165	274	5	asian	NORP
aji-165	274	6	j. immunol	PERSON
aji-165	274	7	8	CARDINAL
aji-165	274	8	1	CARDINAL
aji-165	275	1	104	CARDINAL
aji-165	275	2	2025	DATE
aji-165	275	3	113 4	DATE
aji-165	276	1	4.1	CARDINAL
aji-165	276	2	al.	GPE
aji-165	276	3	2011	DATE
aji-165	277	1	al.	PERSON
aji-165	277	2	0.641	CARDINAL
aji-165	277	3	2015	DATE
aji-165	278	1	canada	GPE
aji-165	278	2	2017	CARDINAL
aji-165	278	3	45567	DATE
aji-165	279	1	lima martins	PERSON
aji-165	279	2	al	PERSON
aji-165	279	3	2018	DATE
aji-165	279	4	2017	CARDINAL
aji-165	279	5	2018	DATE
aji-165	280	1	wang zz	PERSON
aji-165	280	2	al	PERSON
aji-165	281	1	2017	CARDINAL
aji-165	281	2	jm et al.	PERSON
aji-165	281	3	2018	DATE
aji-165	282	1	german	NORP
aji-165	282	2	30 years	DATE
aji-165	282	3	2018	DATE
aji-165	283	1	31.2 ±	PERCENT
aji-165	283	2	3.4 years	DATE
aji-165	283	3	masson	PERSON
aji-165	283	4	2024	DATE
aji-165	284	1	al	PERSON
aji-165	284	2	2018	DATE
aji-165	284	3	nearly 69%	PERCENT
aji-165	284	4	60 years old	DATE
aji-165	284	5	jm et al.	PERSON
aji-165	284	6	2018	DATE
aji-165	285	1	39.7 years ±	DATE
aji-165	286	1	moroccan	NORP
aji-165	286	2	46.67%	PERCENT
aji-165	286	3	n.d.	GPE
aji-165	287	1	68.9%	PERCENT
aji-165	289	1	montreal	GPE
aji-165	289	2	2006	DATE
aji-165	291	1	39.62%	PERCENT
aji-165	291	2	26.41%	PERCENT
aji-165	293	1	2024	DATE
aji-165	294	1	0.04	CARDINAL
aji-165	296	1	dutch	NORP
aji-165	296	2	al.	PERSON
aji-165	296	3	44%	PERCENT
aji-165	296	4	20%	PERCENT
aji-165	296	5	cdi	ORG
aji-165	296	6	7%	PERCENT
aji-165	296	7	uc	ORG
aji-165	296	8	2017	DATE
aji-165	297	1	5.3%	PERCENT
aji-165	299	1	casellas f	PERSON
aji-165	299	2	al.	PERSON
aji-165	299	3	117	CARDINAL
aji-165	299	4	six	CARDINAL
aji-165	299	5	at least one	CARDINAL
aji-165	299	6	58	CARDINAL
aji-165	300	1	uc	ORG
aji-165	300	2	four	CARDINAL
aji-165	300	3	49	CARDINAL
aji-165	300	4	2018	DATE
aji-165	301	1	38	CARDINAL
aji-165	301	2	49.35%	PERCENT
aji-165	301	3	31.17%	PERCENT
aji-165	303	1	moroccan	NORP
aji-165	303	2	20	CARDINAL
aji-165	303	3	33.3%	PERCENT
aji-165	303	4	14	CARDINAL
aji-165	303	5	uc	ORG
aji-165	303	6	23.3%	PERCENT
aji-165	304	1	32	CARDINAL
aji-165	304	2	53.3%	PERCENT
aji-165	304	3	ten	CARDINAL
aji-165	304	4	16.67%	PERCENT
aji-165	304	5	twenty-one	CARDINAL
aji-165	304	6	uc	ORG
aji-165	304	7	35%	PERCENT
aji-165	305	1	25%	PERCENT
aji-165	305	2	uc	ORG
aji-165	305	3	n.d.	GPE
aji-165	306	1	51.95%	PERCENT
aji-165	306	2	19.48%	PERCENT
aji-165	306	3	uc	ORG
aji-165	306	4	45.45%	PERCENT
aji-165	306	5	19.48%	PERCENT
aji-165	306	6	uc	ORG
aji-165	306	7	19.48%	PERCENT
aji-165	306	8	14.28%	PERCENT
aji-165	306	9	uc	ORG
aji-165	306	10	9.09%	PERCENT
aji-165	306	11	7.79%	PERCENT
aji-165	308	1	iranian	NORP
aji-165	308	2	al	PERSON
aji-165	308	3	51.9%	PERCENT
aji-165	308	4	27.9%	PERCENT
aji-165	308	5	22.7%	PERCENT
aji-165	308	6	gao et al.	PERSON
aji-165	308	7	2017	DATE
aji-165	309	1	41.55%	PERCENT
aji-165	309	2	10.4%	PERCENT
aji-165	309	3	nassar et al	PERSON
aji-165	310	1	asian	NORP
aji-165	310	2	j. immunol	PERSON
aji-165	310	3	8	CARDINAL
aji-165	310	4	1	CARDINAL
aji-165	311	1	104	CARDINAL
aji-165	311	2	2025	DATE
aji-165	311	3	114 3.9%	PERCENT
aji-165	313	1	4.2	CARDINAL
aji-165	313	2	fc	GPE
aji-165	313	3	crp	ORG
aji-165	313	4	chinese	NORP
aji-165	313	5	crp	ORG
aji-165	313	6	wang et al.	PERSON
aji-165	313	7	2013	DATE
aji-165	314	1	34	CARDINAL
aji-165	314	2	46.57%	PERCENT
aji-165	314	3	crp	ORG
aji-165	314	4	29.87%	PERCENT
aji-165	316	1	schoepfer	PERSON
aji-165	316	2	al	PERSON
aji-165	316	3	uc	ORG
aji-165	316	4	fc	NORP
aji-165	316	5	0.8	CARDINAL
aji-165	316	6	crp	ORG
aji-165	316	7	0.5	CARDINAL
aji-165	316	8	schoepfer et al.	PERSON
aji-165	316	9	2024	DATE
aji-165	317	1	surabaya	GPE
aji-165	317	2	march to august 2020	DATE
aji-165	317	3	30	CARDINAL
aji-165	317	4	uc	ORG
aji-165	318	1	crp	ORG
aji-165	318	2	fc	NORP
aji-165	319	1	fc	ORG
aji-165	319	2	20	CARDINAL
aji-165	319	3	67%	PERCENT
aji-165	319	4	crp	ORG
aji-165	319	5	13	CARDINAL
aji-165	319	6	43%	PERCENT
aji-165	320	1	fc	NORP
aji-165	320	2	crp	ORG
aji-165	320	3	0.57	CARDINAL
aji-165	320	4	0.01	CARDINAL
aji-165	320	5	2023	CARDINAL
aji-165	321	1	fc	GPE
aji-165	321	2	52.63%	PERCENT
aji-165	321	3	35.9%	PERCENT
aji-165	322	1	0.018	CARDINAL
aji-165	322	2	fc	NORP
aji-165	323	1	fc	GPE
aji-165	323	2	0.1	CARDINAL
aji-165	323	3	uc	ORG
aji-165	324	1	0.27	CARDINAL
aji-165	325	1	fc	ORG
aji-165	326	1	between 2018 and 2019	DATE
aji-165	326	2	49	CARDINAL
aji-165	326	3	31	CARDINAL
aji-165	326	4	the university hospital	ORG
aji-165	326	5	krakow	GPE
aji-165	326	6	poland	GPE
aji-165	327	1	2021	CARDINAL
aji-165	328	1	2006	DATE
aji-165	328	2	italy	GPE
aji-165	328	3	76	CARDINAL
aji-165	328	4	29	CARDINAL
aji-165	328	5	47	CARDINAL
aji-165	328	6	calprotectin	PRODUCT
aji-165	330	1	calprotectin	PRODUCT
aji-165	330	2	uc	ORG
aji-165	330	3	2006	DATE
aji-165	331	1	crp	ORG
aji-165	331	2	6 and ≥6	DATE
aji-165	331	3	0.48	CARDINAL
aji-165	332	1	crp	ORG
aji-165	332	2	0.8	CARDINAL
aji-165	333	1	uc	ORG
aji-165	333	2	0.08	CARDINAL
aji-165	334	1	fc	GPE
aji-165	335	1	fc	NORP
aji-165	335	2	2015	DATE
aji-165	336	1	gecse	PERSON
aji-165	336	2	al	PERSON
aji-165	336	3	5 mm	QUANTITY
aji-165	336	4	297	CARDINAL
aji-165	336	5	1,523	CARDINAL
aji-165	336	6	0.0001	CARDINAL
aji-165	337	1	120	CARDINAL
aji-165	339	1	45%	PERCENT
aji-165	339	2	36.5%	PERCENT
aji-165	339	3	18.5%	PERCENT
aji-165	340	1	fc	ORG
aji-165	340	2	crp	ORG
aji-165	340	3	0.03	CARDINAL
aji-165	340	4	0.0001	CARDINAL
aji-165	340	5	0.03	CARDINAL
aji-165	341	1	fc	NORP
aji-165	341	2	crp	ORG
aji-165	341	3	0.0009	CARDINAL
aji-165	341	4	0.0002	CARDINAL
aji-165	343	1	fc	ORG
aji-165	343	2	0.04	CARDINAL
aji-165	343	3	cdai	ORG
aji-165	343	4	0.0006	CARDINAL
aji-165	344	1	fc	NORP
aji-165	344	2	nassar et al	PERSON
aji-165	345	1	asian	NORP
aji-165	345	2	j. immunol	PERSON
aji-165	345	3	8	CARDINAL
aji-165	345	4	1	CARDINAL
aji-165	346	1	104	CARDINAL
aji-165	346	2	2025	DATE
aji-165	346	3	115	CARDINAL
aji-165	346	4	2015	DATE
aji-165	347	1	273	CARDINAL
aji-165	347	2	41	CARDINAL
aji-165	347	3	189	CARDINAL
aji-165	347	4	fc	ORG
aji-165	347	5	cdai	ORG
aji-165	347	6	0.711	CARDINAL
aji-165	347	7	0.687	CARDINAL
aji-165	347	8	al.	GPE
aji-165	347	9	2015	DATE
aji-165	349	1	88	CARDINAL
aji-165	349	2	twelve	CARDINAL
aji-165	349	3	13.6%	PERCENT
aji-165	350	1	2015	DATE
aji-165	351	1	crp	ORG
aji-165	351	2	0.06	CARDINAL
aji-165	352	1	crp	ORG
aji-165	353	1	4.3	CARDINAL
aji-165	353	2	fc / crp	ORG
aji-165	353	3	the university hospital of saint	ORG
aji-165	353	4	between june 2017	DATE
aji-165	353	5	june 2018	DATE
aji-165	353	6	12 months or until	DATE
aji-165	354	1	fc	NORP
aji-165	354	2	crp	ORG
aji-165	354	3	fc	GPE
aji-165	354	4	26	CARDINAL
aji-165	354	5	105	CARDINAL
aji-165	354	6	three months	DATE
aji-165	354	7	177	CARDINAL
aji-165	354	8	six months	DATE
aji-165	354	9	292	CARDINAL
aji-165	354	10	0.049	CARDINAL
aji-165	354	11	1	CARDINAL
aji-165	354	12	serum crp	PERSON
aji-165	354	13	crp	ORG
aji-165	354	14	1.5 mg/l	QUANTITY
aji-165	354	15	3.3 mg/l	QUANTITY
aji-165	354	16	0.008	CARDINAL
aji-165	355	1	crp	ORG
aji-165	355	2	below 5 mg/l	QUANTITY
aji-165	355	3	li et al.	PERSON
aji-165	355	4	2023	CARDINAL
aji-165	356	1	twenty-six	CARDINAL
aji-165	356	2	five	CARDINAL
aji-165	356	3	twenty-one	CARDINAL
aji-165	356	4	fc	GPE
aji-165	356	5	crp	PERSON
aji-165	356	6	0.2	CARDINAL
aji-165	356	7	sousa et al.	PERSON
aji-165	356	8	2017	DATE
aji-165	357	1	fifty-nine	CARDINAL
aji-165	357	2	eighteen	CARDINAL
aji-165	357	3	30.5%	PERCENT
aji-165	358	1	fc	NORP
aji-165	358	2	278	CARDINAL
aji-165	358	3	16 mg/l	QUANTITY
aji-165	358	4	2022	CARDINAL
aji-165	359	1	273	CARDINAL
aji-165	359	2	tongji medical college	ORG
aji-165	359	3	wuhan	GPE
aji-165	359	4	china	GPE
aji-165	359	5	fc	GPE
aji-165	359	6	26.94	CARDINAL
aji-165	359	7	66.77	CARDINAL
aji-165	359	8	327.22	CARDINAL
aji-165	359	9	0.001	CARDINAL
aji-165	360	1	crp	ORG
aji-165	360	2	3.30	CARDINAL
aji-165	360	3	6.30	CARDINAL
aji-165	360	4	30.30 mg/l	QUANTITY
aji-165	360	5	al.	GPE
aji-165	360	6	2015	DATE
aji-165	361	1	fc	NORP
aji-165	361	2	250 µg	QUANTITY
aji-165	361	3	258	CARDINAL
aji-165	362	1	19 mg/l	QUANTITY
aji-165	362	2	12 mg/l	QUANTITY
aji-165	364	1	fifty	CARDINAL
aji-165	364	2	fc	ORG
aji-165	364	3	crp	ORG
aji-165	365	1	207.46	CARDINAL
aji-165	365	2	11.37 mg/l	QUANTITY
aji-165	365	3	729.85 g/kg	QUANTITY
aji-165	365	4	29.38 mg/l.	QUANTITY
aji-165	365	5	two	CARDINAL
aji-165	366	1	0.001	CARDINAL
aji-165	366	2	crp	ORG
aji-165	366	3	0.0001	CARDINAL
aji-165	366	4	kyle et al.	PERSON
aji-165	366	5	2021	CARDINAL
aji-165	367	1	rodriguez-moranta	PERSON
aji-165	367	2	al.	PERSON
aji-165	367	3	fc	ORG
aji-165	367	4	nassar et al	PERSON
aji-165	368	1	asian	NORP
aji-165	368	2	j. immunol	PERSON
aji-165	368	3	8	CARDINAL
aji-165	368	4	1	CARDINAL
aji-165	369	1	104	CARDINAL
aji-165	369	2	2025	DATE
aji-165	369	3	116	CARDINAL
aji-165	369	4	2014	DATE
aji-165	371	1	al.	PERSON
aji-165	371	2	fc	NORP
aji-165	371	3	fc	NORP
aji-165	371	4	ahmed et al.	PERSON
aji-165	371	5	2017	DATE
aji-165	372	1	fc	NORP
aji-165	372	2	531 µg	QUANTITY
aji-165	372	3	412.6	CARDINAL
aji-165	373	1	0.73	CARDINAL
aji-165	373	2	two	CARDINAL
aji-165	374	1	17.73 mg/l	QUANTITY
aji-165	374	2	6.84 mg/l	QUANTITY
aji-165	374	3	0.03	CARDINAL
aji-165	374	4	two	CARDINAL
aji-165	374	5	crp	ORG
aji-165	375	1	between january 2012	DATE
aji-165	375	2	october 2014	DATE
aji-165	375	3	mumbai	GPE
aji-165	375	4	sixty-three	CARDINAL
aji-165	375	5	32	CARDINAL
aji-165	375	6	31	CARDINAL
aji-165	376	1	crp	ORG
aji-165	376	2	fc	ORG
aji-165	377	1	fc	NORP
aji-165	377	2	1800 mg/g	QUANTITY
aji-165	377	3	619 mg	QUANTITY
aji-165	377	4	0.04	CARDINAL
aji-165	378	1	crp	ORG
aji-165	378	2	0.4	CARDINAL
aji-165	378	3	0.001	CARDINAL
aji-165	379	1	86.9%	PERCENT
aji-165	379	2	fc	NORP
aji-165	379	3	crp	ORG
aji-165	379	4	65.6%	PERCENT
aji-165	379	5	0.01	CARDINAL
aji-165	379	6	2013	DATE
aji-165	380	1	fc	NORP
aji-165	381	1	0.88	CARDINAL
aji-165	382	1	crp	ORG
aji-165	382	2	fc	PERSON
aji-165	382	3	0.12	CARDINAL
aji-165	382	4	0.48	CARDINAL
aji-165	383	1	fc	NORP
aji-165	383	2	crp	ORG
aji-165	383	3	0.12	CARDINAL
aji-165	383	4	0.48	CARDINAL
aji-165	384	1	crp	ORG
aji-165	384	2	fc	NORP
aji-165	384	3	2015	DATE
aji-165	385	1	5	CARDINAL
aji-165	388	1	fc	GPE
aji-165	388	2	crp	PERSON
aji-165	390	1	fc	NORP
aji-165	393	1	copilot	ORG
aji-165	394	1	nassar et al	PERSON
aji-165	395	1	asian	NORP
aji-165	395	2	j. immunol	PERSON
aji-165	395	3	8	CARDINAL
aji-165	395	4	1	CARDINAL
aji-165	396	1	104	CARDINAL
aji-165	396	2	2025	DATE
aji-165	396	3	117	CARDINAL
aji-165	401	1	ahmed	PERSON
aji-165	401	2	r.	NORP
aji-165	401	3	el-atreb	GPE
aji-165	401	4	k. a.	PERSON
aji-165	401	5	hassan, a.	PERSON
aji-165	401	6	abo-amer	PERSON
aji-165	401	7	s.	PERSON
aji-165	401	8	2017	CARDINAL
aji-165	402	1	calprotectin	PRODUCT
aji-165	402	2	crp	PERSON
aji-165	403	1	38(1	CARDINAL
aji-165	403	2	10-5	CARDINAL
aji-165	403	3	m. e.	PERSON
aji-165	403	4	f.	PERSON
aji-165	403	5	mastronardi	PERSON
aji-165	403	6	m. l.	PERSON
aji-165	403	7	penna	GPE
aji-165	403	8	jirillo	ORG
aji-165	403	9	e., & covelli	ORG
aji-165	403	10	2006	DATE
aji-165	404	1	calprotectin	PRODUCT
aji-165	405	1	28(4	CARDINAL
aji-165	405	2	665-681	CARDINAL
aji-165	406	1	https://www.tandfonline.com	ORG
aji-165	406	2	b.	PERSON
aji-165	406	3	t., miftahussurur	GPE
aji-165	406	4	m.	PERSON
aji-165	406	5	nusi	PERSON
aji-165	406	6	i. a.	PERSON
aji-165	406	7	setiawan	GPE
aji-165	407	1	2023	CARDINAL
aji-165	408	1	calprotectin	PRODUCT
aji-165	409	1	16(1	CARDINAL
aji-165	409	2	48	CARDINAL
aji-165	409	3	51	CARDINAL
aji-165	409	4	badawy, a. m.	PERSON
aji-165	409	5	m. a.	PERSON
aji-165	409	6	ali	PERSON
aji-165	409	7	a. e.	PERSON
aji-165	409	8	el halim	PERSON
aji-165	409	9	e. m.	PERSON
aji-165	409	10	mohamed	PERSON
aji-165	409	11	h. i.	PERSON
aji-165	409	12	a. m.	PERSON
aji-165	409	13	2014	DATE
aji-165	410	1	calprotectin	PERSON
aji-165	411	1	menoufia med j	ORG
aji-165	411	2	27(1	CARDINAL
aji-165	411	3	35	DATE
aji-165	412	1	benchimol	PERSON
aji-165	412	2	e. i.	PERSON
aji-165	412	3	kaplan	PERSON
aji-165	412	4	g. g.	PERSON
aji-165	412	5	otley	GPE
aji-165	412	6	a. r.	PERSON
aji-165	412	7	nguyen	PERSON
aji-165	412	8	g. c.	PERSON
aji-165	412	9	f. e.	PERSON
aji-165	413	1	2017	CARDINAL
aji-165	415	1	j gastroenterol	PERSON
aji-165	415	2	112(9	DATE
aji-165	415	3	1412–1422	CARDINAL
aji-165	416	1	cosnes	ORG
aji-165	416	2	j., gower-rousseau	ORG
aji-165	416	3	c.	PERSON
aji-165	416	4	2011	DATE
aji-165	418	1	140(6	CARDINAL
aji-165	418	2	1785	DATE
aji-165	418	3	1794	DATE
aji-165	419	1	d’amico	GPE
aji-165	419	2	rubin	GPE
aji-165	419	3	d. t.	PERSON
aji-165	419	4	p. g.	PERSON
aji-165	419	5	f.	PERSON
aji-165	419	6	b.	PERSON
aji-165	419	7	kobayashi	ORG
aji-165	419	8	t.	GPE
aji-165	419	9	2021	CARDINAL
aji-165	420	1	calprotectin	PRODUCT
aji-165	421	1	united european	NORP
aji-165	421	2	gastroenterol j	PERSON
aji-165	421	3	9(4	CARDINAL
aji-165	421	4	451–460	CARDINAL
aji-165	422	1	gao	PERSON
aji-165	422	2	khan	GPE
aji-165	422	3	s.	GPE
aji-165	422	4	m., & sultan	ORG
aji-165	422	5	2017	CARDINAL
aji-165	424	1	15(1	CARDINAL
aji-165	424	2	83-89	DATE
aji-165	425	1	k. b.	PERSON
aji-165	425	2	brandse	GPE
aji-165	425	3	j. f.	PERSON
aji-165	425	4	van wilpe	PERSON
aji-165	425	5	s.	PERSON
aji-165	425	6	löwenberg	PERSON
aji-165	425	7	m., ponsioen	PERSON
aji-165	425	8	c., van den	PERSON
aji-165	425	9	2015	CARDINAL
aji-165	427	1	scand j gastroenterol	PERSON
aji-165	427	2	50(7	CARDINAL
aji-165	427	3	841–847	CARDINAL
aji-165	428	1	guardiola	ORG
aji-165	428	2	j., lobatón	PERSON
aji-165	428	3	t.	GPE
aji-165	428	4	rodríguez-alonso	ORG
aji-165	428	5	l.	PERSON
aji-165	428	6	ruiz-cerulla	PERSON
aji-165	428	7	c.	GPE
aji-165	428	8	loayza	GPE
aji-165	428	9	2014	DATE
aji-165	429	1	calprotectin	PRODUCT
aji-165	430	1	clin gastroenterol hepatol	PERSON
aji-165	430	2	12(11	DATE
aji-165	430	3	1865–1870	CARDINAL
aji-165	432	1	jm, h., m i, mm	ORG
aji-165	432	2	b. w.	PERSON
aji-165	432	3	2018	DATE
aji-165	433	1	the age of 70 years	DATE
aji-165	434	1	scand j gastroenterol	PERSON
aji-165	434	2	53(9	CARDINAL
aji-165	435	1	https://pubmed.ncbi.nlm.nih.gov/	PERSON
aji-165	435	2	30189153/	CARDINAL
aji-165	435	3	k., konrad	PERSON
aji-165	435	4	m., & jacob	ORG
aji-165	435	5	2018	DATE
aji-165	436	1	germany	GPE
aji-165	437	1	33(7	CARDINAL
aji-165	437	2	967–971	CARDINAL
aji-165	438	1	kyle	PERSON
aji-165	438	2	b. d.	PERSON
aji-165	438	3	t. a.	GPE
aji-165	438	4	sharif	ORG
aji-165	438	5	s.	PERSON
aji-165	438	6	marshall	PERSON
aji-165	438	7	j.	PERSON
aji-165	438	8	halder	GPE
aji-165	438	9	s. l. s.	PERSON
aji-165	438	10	2021	CARDINAL
aji-165	439	1	calprotectin	PRODUCT
aji-165	439	2	crp	ORG
aji-165	440	1	assoc gastroenterol	ORG
aji-165	440	2	4(2	CARDINAL
aji-165	441	1	li	PERSON
aji-165	441	2	j.	PERSON
aji-165	441	3	xu	PERSON
aji-165	441	4	qian	PERSON
aji-165	441	5	w., ling	PERSON
aji-165	441	6	f.	PERSON
aji-165	441	7	chen	PERSON
aji-165	441	8	li	PERSON
aji-165	441	9	s.	PERSON
aji-165	441	10	... & zhu	ORG
aji-165	441	11	2023	CARDINAL
aji-165	442	1	calprotectin	PRODUCT
aji-165	443	1	14	CARDINAL
aji-165	443	2	1186665	DATE
aji-165	444	1	a.	PERSON
aji-165	444	2	& mdp	ORG
aji-165	444	3	z. g.	PERSON
aji-165	444	4	2018	DATE
aji-165	445	1	brazilian	NORP
aji-165	447	1	asian	NORP
aji-165	447	2	j. immunol	PERSON
aji-165	447	3	8	CARDINAL
aji-165	447	4	1	CARDINAL
aji-165	448	1	104	CARDINAL
aji-165	448	2	2025	DATE
aji-165	448	3	118	CARDINAL
aji-165	449	1	18(1	CARDINAL
aji-165	450	1	https://pubmed.ncbi.nlm.nih.gov/	PERSON
aji-165	450	2	29914399/	CARDINAL
aji-165	450	3	d.	NORP
aji-165	450	4	mo	GPE
aji-165	450	5	mm	PERSON
aji-165	450	6	2015	DATE
aji-165	452	1	8(3	DATE
aji-165	452	2	4	CARDINAL
aji-165	453	1	https://pubmed.ncbi.nlm.nih.gov/	PERSON
aji-165	453	2	27785298/	CARDINAL
aji-165	453	3	battat	GPE
aji-165	453	4	r.	NORP
aji-165	453	5	khanna	PERSON
aji-165	453	6	r.	NORP
aji-165	453	7	parker	GPE
aji-165	453	8	c. e.	PERSON
aji-165	453	9	b. g.	PERSON
aji-165	453	10	2019	CARDINAL
aji-165	454	1	calprotectin	PRODUCT
aji-165	455	1	clin gastroenterol	PERSON
aji-165	455	2	101602	DATE
aji-165	457	1	2024	CARDINAL
aji-165	458	1	e.	PERSON
aji-165	458	2	2024	CARDINAL
aji-165	459	1	algeria	GPE
aji-165	461	1	s.	GPE
aji-165	461	2	paupard	PERSON
aji-165	461	3	t.	GPE
aji-165	461	4	m., clair	ORG
aji-165	461	5	e., & abitbol	ORG
aji-165	461	6	2018	DATE
aji-165	463	1	gastroenterol hepatol	PERSON
aji-165	463	2	1125	CARDINAL
aji-165	463	3	1129	CARDINAL
aji-165	464	1	rodríguez-moranta	PERSON
aji-165	464	2	l., & guardiola	ORG
aji-165	464	3	j. (	PERSON
aji-165	464	4	2013	DATE
aji-165	465	1	calprotectin	PRODUCT
aji-165	466	1	gastroenterol hepatol	PERSON
aji-165	466	2	36(6	CARDINAL
aji-165	466	3	400–406	CARDINAL
aji-165	466	4	samant	PERSON
aji-165	466	5	desai	PERSON
aji-165	466	6	d.	NORP
aji-165	466	7	abraham	PERSON
aji-165	466	8	joshi, a.	PERSON
aji-165	466	9	gupta	GPE
aji-165	466	10	t.	GPE
aji-165	466	11	dherai, a.	ORG
aji-165	467	1	2015	CARDINAL
aji-165	468	1	calprotectin	PRODUCT
aji-165	468	2	india	GPE
aji-165	469	1	indian	NORP
aji-165	469	2	j gastroenterol	PERSON
aji-165	469	3	431–435	CARDINAL
aji-165	470	1	b. e.	PERSON
aji-165	470	2	2015	DATE
aji-165	472	1	149(5	CARDINAL
aji-165	472	2	1275	CARDINAL
aji-165	473	1	satsangi	PERSON
aji-165	473	2	j., silverberg	PERSON
aji-165	473	3	m. s.	PERSON
aji-165	473	4	s., & colombel	ORG
aji-165	473	5	j. f. (	PERSON
aji-165	473	6	2006	DATE
aji-165	475	1	55(6	CARDINAL
aji-165	475	2	749–753	CARDINAL
aji-165	476	1	schoepfer	PERSON
aji-165	476	2	a. m.	PERSON
aji-165	476	3	a.	GPE
aji-165	476	4	safroneeva	GPE
aji-165	476	5	e., romero	ORG
aji-165	476	6	armstrong	PERSON
aji-165	476	7	d.	NORP
aji-165	476	8	schmidt	GPE
aji-165	476	9	m.	PERSON
aji-165	476	10	s. r.	PERSON
aji-165	476	11	2024	DATE
aji-165	476	12	calprotectin	PRODUCT
aji-165	477	1	k.	PERSON
aji-165	477	2	pawlica-gosiewska	PERSON
aji-165	477	3	d.	NORP
aji-165	477	4	k.	PERSON
aji-165	477	5	d.	NORP
aji-165	477	6	d.	NORP
aji-165	477	7	pocztar	GPE
aji-165	477	8	2021	CARDINAL
aji-165	479	1	17(1	CARDINAL
aji-165	479	2	252	CARDINAL
aji-165	479	3	c. s.	PERSON
aji-165	479	4	groenen	ORG
aji-165	479	5	m. j. m.	PERSON
aji-165	479	6	van koolwijk	PERSON
aji-165	479	7	e. h. m.	PERSON
aji-165	479	8	wahab	PERSON
aji-165	479	9	p. j.	PERSON
aji-165	479	10	e. g.	PERSON
aji-165	479	11	2017	CARDINAL
aji-165	481	1	scand j gastroenterol	PERSON
aji-165	481	2	52(10	CARDINAL
aji-165	481	3	1104–1112	CARDINAL
aji-165	482	1	martins	PERSON
aji-165	482	2	d.	NORP
aji-165	482	3	j., cancela	ORG
aji-165	482	4	r.	NORP
aji-165	482	5	r.	NORP
aji-165	482	6	2017	CARDINAL
aji-165	484	1	crohn	ORG
aji-165	484	2	11(suppl_1	DATE
aji-165	484	3	s207	NORP
aji-165	486	1	krela-kazmierczak	PERSON
aji-165	486	2	i.	PERSON
aji-165	486	3	klimczak	PERSON
aji-165	486	4	k.	PERSON
aji-165	486	5	2015	CARDINAL
aji-165	487	1	calprotectin	PRODUCT
aji-165	489	1	sci	ORG
aji-165	489	2	11(2	CARDINAL
aji-165	489	3	353–361	CARDINAL
aji-165	490	1	swaminathan, a., & day	ORG
aji-165	490	2	a. s.	PERSON
aji-165	490	3	2024, august	DATE
aji-165	492	1	dis sci	PERSON
aji-165	492	2	69(8	CARDINAL
aji-165	492	3	2723–2724	DATE
aji-165	493	1	torres	PERSON
aji-165	493	2	j.	PERSON
aji-165	493	3	s.	PERSON
aji-165	493	4	j. f., & peyrin	PERSON
aji-165	493	5	2017	CARDINAL
aji-165	494	1	crohn	PERSON
aji-165	495	1	lancet	ORG
aji-165	495	2	389(10080	CARDINAL
aji-165	495	3	1741–1755	CARDINAL
aji-165	496	1	https://pubmed.ncbi.nlm.nih.gov/29914399/	LOC
aji-165	497	1	nassar et al	PERSON
aji-165	497	2	asian	NORP
aji-165	497	3	j. immunol	PERSON
aji-165	497	4	8	CARDINAL
aji-165	497	5	1	CARDINAL
aji-165	498	1	104	CARDINAL
aji-165	498	2	2025	DATE
aji-165	498	3	119	CARDINAL
aji-165	499	1	2024, december 28	DATE
aji-165	500	1	27914657/	CARDINAL
aji-165	500	2	roblin	PERSON
aji-165	500	3	x.	GPE
aji-165	500	4	r.	NORP
aji-165	500	5	s.	GPE
aji-165	500	6	killian	PERSON
aji-165	500	7	m.	PERSON
aji-165	500	8	s.	PERSON
aji-165	500	9	2022	CARDINAL
aji-165	501	1	calprotectin	PRODUCT
aji-165	502	1	2	CARDINAL
aji-165	502	2	33	CARDINAL
aji-165	503	1	wang	ORG
aji-165	503	2	x. q.	PERSON
aji-165	503	3	zhang	PERSON
aji-165	503	4	xu	PERSON
aji-165	503	5	c. d.	PERSON
aji-165	503	6	jiang	GPE
aji-165	503	7	l. r.	PERSON
aji-165	503	8	huang	PERSON
aji-165	503	9	du	PERSON
aji-165	503	10	h. m.	PERSON
aji-165	503	11	2013	DATE
aji-165	504	1	chinese	NORP
aji-165	504	2	a decade	DATE
aji-165	504	3	shanghai	GPE
aji-165	505	1	inflamm bowel dis	ORG
aji-165	505	2	19(2	DATE
aji-165	505	3	423–428	CARDINAL
aji-165	589	1	2025	DATE
aji-165	593	1	https://pubmed.ncbi.nlm.nih.gov/27914657/	PERSON